These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Protein kinase Cθ controls type 2 innate lymphoid cell and T Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240 [TBL] [Abstract][Full Text] [Related]
10. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. Pesce JT; Ramalingam TR; Mentink-Kane MM; Wilson MS; El Kasmi KC; Smith AM; Thompson RW; Cheever AW; Murray PJ; Wynn TA PLoS Pathog; 2009 Apr; 5(4):e1000371. PubMed ID: 19360123 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A indirectly attenuates activation of group 2 innate lymphoid cells in papain-induced lung inflammation. Kudo F; Ikutani M; Iseki M; Takaki S Cell Immunol; 2018 Jan; 323():33-40. PubMed ID: 29108648 [TBL] [Abstract][Full Text] [Related]
12. Sensing and signaling of immunogenic extracellular RNAs restrain group 2 innate lymphoid cell-driven acute lung inflammation and airway hyperresponsiveness. She L; Alanazi HH; Yan L; Brooks EG; Dube PH; Xiang Y; Zhang F; Sun Y; Liu Y; Zhang X; Li XD PLoS One; 2020; 15(7):e0236744. PubMed ID: 32730309 [TBL] [Abstract][Full Text] [Related]
13. Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation. Morikawa T; Fukuoka A; Matsushita K; Yasuda K; Iwasaki N; Akasaki S; Fujieda S; Yoshimoto T Int Immunol; 2017 May; 29(5):221-233. PubMed ID: 28541554 [TBL] [Abstract][Full Text] [Related]
14. Pivotal Advance: Arginase-1-independent polyamine production stimulates the expression of IL-4-induced alternatively activated macrophage markers while inhibiting LPS-induced expression of inflammatory genes. Van den Bossche J; Lamers WH; Koehler ES; Geuns JM; Alhonen L; Uimari A; Pirnes-Karhu S; Van Overmeire E; Morias Y; Brys L; Vereecke L; De Baetselier P; Van Ginderachter JA J Leukoc Biol; 2012 May; 91(5):685-99. PubMed ID: 22416259 [TBL] [Abstract][Full Text] [Related]
15. Allergen-Experienced Group 2 Innate Lymphoid Cells Acquire Memory-like Properties and Enhance Allergic Lung Inflammation. Martinez-Gonzalez I; Mathä L; Steer CA; Ghaedi M; Poon GF; Takei F Immunity; 2016 Jul; 45(1):198-208. PubMed ID: 27421705 [TBL] [Abstract][Full Text] [Related]
16. Metabolic regulation by PPARγ is required for IL-33-mediated activation of ILC2s in lung and adipose tissue. Fali T; Aychek T; Ferhat M; Jouzeau JY; Busslinger M; Moulin D; Eberl G Mucosal Immunol; 2021 May; 14(3):585-593. PubMed ID: 33106586 [TBL] [Abstract][Full Text] [Related]
17. Basophils prime group 2 innate lymphoid cells for neuropeptide-mediated inhibition. Inclan-Rico JM; Ponessa JJ; Valero-Pacheco N; Hernandez CM; Sy CB; Lemenze AD; Beaulieu AM; Siracusa MC Nat Immunol; 2020 Oct; 21(10):1181-1193. PubMed ID: 32807943 [TBL] [Abstract][Full Text] [Related]
18. ICAM-1 controls development and function of ILC2. Lei AH; Xiao Q; Liu GY; Shi K; Yang Q; Li X; Liu YF; Wang HK; Cai WP; Guan YJ; Gabrilovich DI; Zhou J J Exp Med; 2018 Aug; 215(8):2157-2174. PubMed ID: 30049704 [TBL] [Abstract][Full Text] [Related]
19. NK Cells Alleviate Lung Inflammation by Negatively Regulating Group 2 Innate Lymphoid Cells. Bi J; Cui L; Yu G; Yang X; Chen Y; Wan X J Immunol; 2017 Apr; 198(8):3336-3344. PubMed ID: 28275135 [TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway. Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]